Global spending on medications will reach $1.4 trillion by 2020 due to greater patient access to chronic disease treatments and breakthrough innovations in drug therapies, according to a new report.
Global spending on medications will reach $1.4 trillion by 2020 due to greater patient access to chronic disease treatments and breakthrough innovations in drug therapies, according to a new report.
The report Global Medicines Use in 2020: Outlook and Implications, published by IMS Institute for Healthcare Informatics, predicts global drug spending will grow 4–7% during the next five years.
In the United States, spending on medicines will reach between $560 billion and $590 billion in 2020, a 34% increase in spending over 2015. In addition, more than 90% of U.S. medicines will be dispensed as generics by 2020.
Total global spend for pharmaceuticals during the next five years will increase by $349 billion, compared to the $182 billion increase during the past five years.
“During the next five years, we expect to see a surge of innovative medicines emerging from R&D pipelines, as well as technology-enabled advances that will deliver measurable improvements to health outcomes,” said Murray Aitken, IMS Health’s senior vice president and executive director of the IMS Institute for Healthcare Informatics.
“With unprecedented treatment options, greater availability of low-cost drugs, and better use of evidence to inform decision making, stakeholders around the world can expect to get more bang for their medicine buck in 2020 than ever before,” Aitken said.
Other report findings include:
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.